Search

Benign prostate hypertrophy (BPH) is one of the most common causes of lower urinary tract symptoms (LUTS) in elderly men. BPH is caused by a combination of the proliferation of the prostate and obstruction of the lower urinary tract. Patients benefitted from both standard treatment and nurse-directed education programs; however, the improvement in symptom severity and physical component of quality of life were greater in patients who received the nursedirected education program. [ABSTRACT FROM AUTHOR]

Background: In a developing country like India where mobile phone usage is increasing at an exponential rate, tele monitoring techniques could be used to reduce cardiac related morbidity and mortality. The current study was undertaken to evaluate the acceptance and feasibility of handheld tele-ECG for screening general population for cardiac related abnormalities. Methods: The study was conducted among walk-in patients and their attenders of an urban health training centre attached a tertiary care teaching hospital for a period of 6 months in 2019. Results: Among the 410 respondents, majority were of age group 30-39yrs (54%) and females (62%). Left ventricular hypertrophy (15.4%) was the commonest abnormality. Majority (97.5%) were very satisfied with the hand held Tele-ECG instrument. Conclusion: Telecardiology has a potential to revolutionize the healthcare system particularly in resource poor rural and urban slum settings in bridging the gap between primary and secondary care. [ABSTRACT FROM AUTHOR]

Hypertension is common in children with chronic kidney disease (CKD) and is a major determinant of CKD progression. Ambulatory blood pressure monitoring (ABPM) has been proposed to be better in detecting hypertension as compared to casual blood pressure (CBP). This study aims to study the usefulness of ABPM in detecting masked hypertension, evaluating the adequacy of blood pressure (BP) control and predicting left ventricular hypertrophy (LVH) amongst children with CKD. A prospective cross-sectional study of 46 children with stage 3-5 CKD was conducted at the Pediatric Nephrology department of a tertiary hospital in South India. All children underwent CBP, ABPM and an echocardiography. Results were categorized as normal BP; confirmed hypertension; masked hypertension and white coat hypertension. Out of 46 children studied, 11 were undergoing dialysis. While 39.1 % children had stage 3 and 4 CKD each, 21.7% had stage 5 CKD. Masked hypertension was detected in 19.6% and 21.7% had confirmed hypertension. Thirty-four (73.9%) children were already receiving antihypertensive medication. In these, CBP was elevated in 23.5% and ABP in 47%. Among children with hypertension as defined by ABPM, LVH was detected in 32.2%. We found that higher the number of abnormal ABPM indices (assessed by BP Index, nocturnal dipping and BP Load) higher the likelihood of LVH (P = 0.046). ABPM is better in detecting hypertension and monitoring adequacy of treatment in children with CKD. The high prevalence of masked hypertension and its association with LVH supports early echocardiography and ambulatory BP monitoring to evaluate cardiovascular risks in this population. [ABSTRACT FROM AUTHOR]

Objectives:To study the role of mometasone furoate aqueous nasal spray for the management of adenoidal hypertrophy in children with more than 50 per cent obstruction, and to assess its impact on change in quality of life.Methods:A prospective, randomised, double-blind, interventional placebo-controlled study was conducted. A total of 100 children aged 2–12 years completed treatment and follow up. The symptoms and degree of obstruction were evaluated by nasopharyngoscopy conducted pre-treatment and 24 weeks post-treatment. Subjects received mometasone furoate nasal spray at a daily dose of 200 µg for 8 weeks, followed by a dose of 200 µg on alternate days for 16 weeks. Results were compared with those of a matched control group who were given saline nasal spray.Results:With mometasone treatment, there was an 89.8 per cent reduction in clinical symptom score, and the degree of obstruction dropped from 87 to 72 per cent (p < 0.0001). A statistically significant change in quality of life scores was seen in patients treated with the mometasone nasal spray (score change of 37.47) as compared with those given saline nasal spray (score change of 11.25) (p = 0.0001).Conclusion:Mometasone nasal spray appears to be effective in treating children with obstructive adenoids. [ABSTRACT FROM PUBLISHER]